文献速递肝胆胰外科

纯腹腔镜与开腹右半肝切除治疗肝硬化肝癌的倾向评分匹配分析

Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Propensity Score Matched Analysis.
PubMed 文献 · Ann Surg · 2017-01-01

该回顾性研究纳入2008年6月至2015年7月韩国Asan医学中心152例肝硬化肝癌患者,其中纯腹腔镜右半肝切除37例、开腹右半肝切除115例,经1:1倾向评分匹配后每组33例。结果显示两组并发症发生率无统计学差异(P=0.053),但腹腔镜组综合并发症指数显著更低(0.63 vs 4.42,P=0.025),2年无病生存率和2年总生存率均无显著差异。结论认为在肝硬化患者中纯腹腔镜右半肝切除的安全性不劣于开腹手术,肿瘤学结局相当。

要点

  • 肝硬化肝癌患者行纯腹腔镜右半肝切除,并发症发生率与开腹手术无统计学差异。
  • 腹腔镜组综合并发症指数显著低于开腹组,提示并发症严重程度更轻。
  • 两组2年无病生存率和2年总生存率无显著差异,肿瘤学结局相当。

核心结论

  • 在肝硬化肝癌患者中,纯腹腔镜右半肝切除的安全性不劣于传统开腹途径。
  • 两组肿瘤学结局相当,在选定患者中纯腹腔镜右半肝切除可作为开腹手术的可行替代方案。

研究设计与样本

  • 回顾性队列研究,纳入2008年6月至2015年7月韩国Asan医学中心152例肝硬化肝癌患者。
  • 纯腹腔镜右半肝切除组37例,开腹右半肝切除组115例,行1:1倾向评分匹配后每组33例。

主要发现

  • 两组并发症发生率无统计学显著差异(P=0.053)。
  • 腹腔镜组平均综合并发症指数显著低于开腹组(0.63 vs 4.42;P=0.025)。
  • 两组2年无病生存率无显著差异(P=0.645)。
  • 两组2年总生存率无显著差异(P=0.090)。

临床怎么用

  • 对肝硬化肝癌患者,纯腹腔镜右半肝切除可作为开腹手术的可行替代方案,但需选择合适患者。
  • 综合并发症指数提示腹腔镜组并发症严重程度更低,围术期管理可据此评估获益。

局限性

  • 本研究为单中心回顾性分析,样本量有限,匹配后每组仅33例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to describe our experience with pure laparoscopic right hepatectomy (LRH) and to compare its outcomes with those of open right hepatectomy (ORH) in hepatocellular carcinoma (HCC) patients with liver cirrhosis. BACKGROUND: Laparoscopic liver resection has been reported as a safe and effective approach for the management of liver cancer; however, its outcomes have not been evaluated in a large cohort of HCC patients with liver cirrhosis. METHODS: We retrospectively reviewed the medical records of 152 patients who underwent pure LRH (n = 37) or ORH (n = 115) between June 2008 and July 2015 at the Asan Medical Center in Seoul, Korea. We performed 1:1 propensity score matching between the LRH and ORH groups. Subsequently, 33 patients were included in each group. RESULTS: There was no statistically significant difference between the LRH and ORH groups regarding the rate of complications (P = 0.053). However, the mean comprehensive complication index, which accounts for the severity of complications, was significantly lower in the LRH group (0.63 vs 4.42; P = 0.025). There were no significant differences between the LRH and ORH groups regarding 2-year disease-free survival rate or 2-year overall survival rate (P = 0.645 and P = 0.090, respectively). CONCLUSIONS: Even in patients with cirrhosis, pure LRH is not less safe than the traditional open approach. The oncological outcomes of HCC were also comparable between the two groups. In selected patients, pure LRH for HCC appears to represent a viable alternative to ORH.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Yoon YI, Kim KH, Kang SH, et al. Pure Laparoscopic Versus Open Right Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Propensity Score Matched Analysis. Ann Surg. 2017. PMID: 27849661. doi:10.1097/SLA.0000000000002072

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。